A novel 3-phytosterone-9α-hydroxylase oxygenation component and its application in bioconversion of 4-androstene-3,17-dione to 9α-hydroxy-4-androstene-3,17-dione coupling with a NADH regeneration formate dehydrogenase

Article abstract of DOI:10.3390/molecules24142534

9α-Hydroxy-4-androstene-3,17-dione (9-OH-AD) is one of the significant intermediates for the preparation of β-methasone, dexamethasone, and other steroids. In general, the key enzyme that enables the biotransformation of 4-androstene-3,17-dione (AD) to 9-OH-AD is 3-phytosterone-9α-hydroxylase (KSH), which consists of two components: a terminal oxygenase (KshA) and ferredoxin reductase (KshB). The reaction is carried out with the concomitant oxidation of NADH to NAD⁺. In this study, the more efficient 3-phytosterone-9α-hydroxylase oxygenase (KshC) from the Mycobacterium sp. strain VKM Ac-1817D was confirmed and compared with reported KshA. To evaluate the function of KshC on the bioconversion of AD to 9-OH-AD, the characterization of KshC and the compounded system of KshB, KshC, and NADH was constructed. The optimum ratio of KSH oxygenase to reductase content was 1.5:1. An NADH regeneration system was designed by introducing a formate dehydrogenase, further confirming that a more economical process for biological transformation from AD to 9-OH-AD was established. A total of 7.78 g of 9-OH-AD per liter was achieved through a fed-batch process with a 92.11% conversion rate (mol/mol). This enzyme-mediated hydroxylation method provides an environmentally friendly and economical strategy for the production of 9-OH-AD.

Full text of DOI:10.3390/molecules24142534

molecules
Article
A Novel 3-Phytosterone-9α-Hydroxylase Oxygenation
Component and Its Application in Bioconversion of
4
9
-Androstene-3,17-Dione to
α-Hydroxy-4-Androstene-3,17-Dione Coupling with
A NADH Regeneration Formate Dehydrogenase
Xian Zhang 1 , Manchi Zhu , Rumeng Han , Youxi Zhao , Kewei Chen , Kai Qian ,
1
1
2
3
4
1
1
1
1,
1,
Minglong Shao , Taowei Yang , Meijuan Xu , Jianzhong Xu * and Zhiming Rao *
1
The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology,
Jiangnan University, 1800 Liu Avenue, Wuxi 214122, Jiangsu, China
Biochemical Engineering College, Beijing Union University, Beijing 100023, China
School of Food Science and Technology, Jiangnan University, 1800 Liu Avenue, Wuxi 214122, Jiangsu, China
School of Medicine, Yichun University, Yichun 336000, Jiangxi, China
2
3
4
*
Correspondence: xujianzhong@jiangnan.edu.cn (J.X.); raozhm@jiangnan.edu.cn (Z.R.);
Tel.: +86-1585-283-4439 (J.X.); +86-1392-113-5816 (Z.R.)
ꢀ
ꢁꢂꢀꢃꢄꢅꢆꢇ
ꢀ
ꢁꢂꢃꢄꢅꢆ
Received: 22 May 2019; Accepted: 9 July 2019; Published: 11 July 2019
Abstract:
preparation of
the biotransformation of 4-androstene-3,17-dione (AD) to 9-OH-AD is 3-phytosterone-9
9
α
-Hydroxy-4-androstene-3,17-dione (9-OH-AD) is one of the significant intermediates for the
-methasone, dexamethasone, and other steroids. In general, the key enzyme that enables
-hydroxylase
KSH), which consists of two components: a terminal oxygenase (KshA) and ferredoxin reductase
β
α
(
(
+
KshB). The reaction is carried out with the concomitant oxidation of NADH to NAD . In this study,
-hydroxylase oxygenase (KshC) from the Mycobacterium sp. strain
the more efficient 3-phytosterone-9
α
VKM Ac-1817D was confirmed and compared with reported KshA. To evaluate the function of KshC
on the bioconversion of AD to 9-OH-AD, the characterization of KshC and the compounded system of
KshB, KshC, and NADH was constructed. The optimum ratio of KSH oxygenase to reductase content
was 1.5:1. An NADH regeneration system was designed by introducing a formate dehydrogenase,
further confirming that a more economical process for biological transformation from AD to 9-OH-AD
was established. A total of 7.78 g of 9-OH-AD per liter was achieved through a fed-batch process
with a 92.11% conversion rate (mol/mol). This enzyme-mediated hydroxylation method provides an
environmentally friendly and economical strategy for the production of 9-OH-AD.
Keywords: 9α-Hydroxy-4-androstene-3,17-dione; 3-phytosterone-9α-hydroxylase; hydroxylation;
NADH regeneration
1
. Introduction
Currently, steroids are widely used in anti-tumor, anti-inflammation, anti-microbial, anti-viral,
and antifungal drugs among others, and they are the most important drugs apart from antibiotics.
Steroid compounds usually have a series of unique physiological functions that mainly result
from differences in the position of the substituent or double bond or in the configuration [1].
Mycobacteria have the advantage of using natural sterols or other steroids as the only carbon and energy
sources. Previous research has shown that by interrupting mycobacterial pathways, some important
intermediates can be accumulated, such as 4-androstene-3,17-dione (AD), 1,4-androstene-3,17-dione
(
ADD), and 9α-hydroxy-4-androstene-3,17-dione (9-OH-AD) and so on [2], which can then be used
Molecules 2019, 24, 2534; doi:10.3390/molecules24142534
www.mdpi.com/journal/molecules

Molecules 2019, 24, 2534
2 of 13
as precursors in producing steroid hormones. AD and ADD can be used commercially to produce
glucocorticoids, oral contraceptives, and other steroid drugs. 9-OH-AD can be used to produce
glucocorticoid drugs by replacing the 9α-hydroxyl group with a halogen group; thus, 9-OH-AD is an
important precursor for the preparation of steroid drugs [3–5].
The hydroxylation of steroids is widespread in microorganisms. The effects and mechanisms
of steroid drugs with different substituent positions or different conformations, including those
with 9-
The specificity of the hydroxylation reaction depends on the catalytic enzyme used in the process.
-Phytosterone-9 -hydroxylase (KSH), which was used in this study, is a key microbial steroid metabolic
enzyme that widely exists in microorganisms, such as Rhodococcus [ ], Mycobacterium [ ], Nocardia [ ],
and Arthrobacter [ ]. KSH is composed of two different components, including KSH oxygenase (KshA)
α, 11-α, 11-β, 15-α, and 16-α hydroxylation, also vary; 9-OH-AD is hydroxylated from AD.
3
α
6
7
8
9
and KSH reductase (KshB), which are encoded by the genes kshA and kshB, respectively. Petrusma
et al. confirmed that the function of KSH in Rhodococcus erythropolis SQ1 must be completed by two
components, both of which are necessary [
an NAD-binding domain and a [2Fe-2S] redox center, is responsible for transferring the reductive force
from NADH to KshA. The hydroxylation reaction and the binding of O with the substrate occurs
6]. The reductase component KshB, which contains FAD,
2
2+
in the non-heme Fe -binding region of KshA. In addition, KshB, functioning as a reductive force,
can also play a role in other reactions in an organism [10].
At present, most studies have been focused on the production of 9-OH-AD by bacterial fermentation.
An increasing number of microorganisms have been screened for the ability to modify steroid
molecules to promote the development of steroid drugs [11–14]. However, there must be some
rate-limiting steps and rate-limiting enzymes in the sterol degradation pathway. In addition, because
3
9
-ketosteroid-
-OH-AD is hindered, leading to a low conversion rate with a longer fermentation period, greatly reducing
18]. For example, Donova et al. used the mutant Mycobacterium sp. 2-4 M
∆1-dehydrogenase (Ksdd) can catalyze the conversion of AD to ADD, the accumulation of
the production efficiency [15
–
strain to produce 9-OH-AD, and the conversion rate (mol/mol) was approximately 50% [19]. The KshA,
KshB and glucose dehydrogenase (GDH) of Mycobacterium neoaurum JC-12 were coexpressed in Bacillus
subtilis 168, and the effective conversion of AD to 9-OH-AD was realized [20]. In mycobacteria, knocking
out the gene ksdd and overexpressing KshA leads to the accumulation of 9-OH-AD (approximately
6.78 to 7.33 g/L), but the fermentation period exceeds 150 h [21]. Mycobacterium sp. VKM Ac-1817D
(GenBank accession number: CP009914) can use phytosterol as a substrate to produce 9-OH-AD by
bioconversion. Although the product contains 20% by-products such as ADD and 9-OH-ADD [22],
this strain of bacterium produces relatively high yields of 9-OH-AD. Therefore, this strain was selected
as the source of KSH in this study. From searches on the genome of Mycobacterium sp. VKM Ac-1817D,
three genes kshA, kshB, and ksh annotated as KSH oxygenase, KSH reductase, KSH, respectively, were
found. To make it easier to distinguish these genes, we renamed ksh as kshC, and the coding enzymes of
the three genes were KshA, KshB, and KshC, respectively.
Given that the reductive force of the conversion process, NADH, must be restored, this study
constructed a coupled system formed by hydroxylation catalyzed by KSH and coenzyme regeneration
catalyzed by formate dehydrogenase (FDH) (Figure 1), thus greatly reducing the transformation
period, improving the conversion rate, and reducing the cost, resulting in a more economical and
practical system.
NADH regeneration strategies, such as enzymatic, biological, electrochemical, chemical,
and photochemical methods, have been developed [23]. FDH, which catalyzes the oxidation of
formate to carbon dioxide, is an enzyme that is capable of regenerating NADH. The advantages of using
FDH in the coenzyme regeneration system include the following: Formic acid is relatively cheap as a
substrate; little damage occurs to the enzyme; as a gas, CO can be separated directly without inhibiting
2
product formation [24]; the pH application range is relatively wide; and FDH can play a highly effective
and stable catalytic role in the range of pH 6 to 9 [25]. Furthermore, the reaction is irreversible and
can obviously improve the recovery of the product. Multiple reports describe FDH double enzyme

Molecules 2019, 24, 2534
3 of 13
coupling, which is widely used in oxidation-reduction reactions. In 2002, Matsuyama et al. expressed
alcohol dehydrogenase and FDH in Escherichia coli and used the whole cells to transform acetic acid ethyl
acetate into (S)-4-chloro-3-hydroxybutyrate via an asymmetric reduction [26]. Galkin determined that
more than one amino acid dehydrogenase in E. coli was expressed, including leucine dehydrogenase
and phenylalanine dehydrogenase, and these amino acid dehydrogenases, along with formic acid
dehydrogenase, produce L-alanine [27]. We propose an alternative strategy for the production of
9-OH-AD by KSH coupled with the regeneration of NADH by FDH.
Figure 1. Coupled reaction of hydroxylation and NADH regeneration. KSH: 3-phytosterone-9α-
hydroxylase. FDH: formate dehydrogenase. AD: 4-androstene-3,17-dione. 9-OH-AD: 9
androstene-3,17-dione.
α-hydroxy-4-
2
. Results and Discussion
2
.1. Heterologous Expression and Identification of the KshA, KshB, and KshC Proteins in E. coli
By searching of the genome of Mycobacterium sp. VKM Ac-1817D (GenBank accession
number: CP009914), three genes—shA (encoding the 3-ketosteroid-9-alpha-hydroxylase oxygenase
component), kshB (encoding the 3-ketosteroid-9-alpha-hydroxylase oxygenase component), and ksh
(named kshC in this work; it has an unknown function and was annotated as encoding the
3-ketosteroid-9-alpha-hydroxylase)—were found. The KSH genes were synthesized according
to the codon preferences of E. coli. The amplified primers used were designed and synthesized
based on the full-length of these ksh sequences; therefore, kshA, kshB, and kshC were recovered as
1164-bp, 1059-bp, and 1164-bp fragments, respectively. After the ligation of ksh and pet-28a(+),
as well as the transformation of the plasmids into E. coli BL21 (DE3), the recombinant bacteria,
BL21 (DE3)/pet-28a(+)-ksh, were randomly selected from the kanamycin-resistant agar-plates, and the
plasmids were extracted and confirmed by restriction enzyme digestion using BamH I and Hind III
for single/double cut. As shown in Supplementary File 1: Figure S1, the double enzyme digestion
produced a band that is consistent with the size of the target gene; therefore, it can be preliminarily
concluded that each recombinant plasmid contained a ksh. The target gene was successfully ligated to
pet-28a(+) and transformed into E. coli BL21 (DE3).
The engineered strains BL21 (DE3)/pet-28a(+)-kshA, BL21 (DE3)/pet-28a(+)-kshB, and BL21
(DE3)/pet-28a(+)-kshC were induced by the methods described in the Materials and Methods section,
and the expression of the target proteins was then detected by SDS-PAGE. The results showed that the
expression levels of the KshA and KshB proteins were higher than 30% of the total protein, and the
expressed protein was mainly soluble. A clear band can be seen near 45 kDa, which is consistent
with the expected size (KshA at 44.23 kDa and KshB at 37.48 kDa). However, in the present work,

Molecules 2019, 24, 2534
4 of 13
the SDS-PAGE results showed that almost all of the KshC protein produced was in the insoluble
fraction and was considered to be inclusion bodies (Figure 2), an aggregated form of inactive proteins.
KshC
KshA
KshB
Figure 2. SDS-PAGE analysis of proteins in the parent bacteria and recombinant bacteria. (
protein marker (kDa); C: supernatant of E. coli BL21/pET-28a; 1: sediment of E. coli BL21/pET-28a-kshC
: supernatant of E. coli BL21/pET-28a-kshC; 3: supernatant of E. coli BL21/pET-28a-kshA. ( ) M: protein
marker (kDa); C: supernatant of E. coli BL21/pET-28a; 1: supernatant of E. coli BL21/pET-28a-kshB;
: purified supernatant of E. coli BL21/pET-28a-kshB.
a) M:
2
b
2
It is imperative to reduce the formation of insoluble substances and increase the yield of soluble
KshC because of the severe reduction in the production of soluble KshC and the inhibition of KshC
activity by inclusion bodies. In this study, the problem of expressing soluble KshC was solved by
means of changing the expression vector. The kshC gene was ligated to the pEtDuet-1 plasmid to
construct the recombinant bacterium E. coli BL21 (DE3)/pEtDuet-1-kshC; this bacterium successfully
expressed KshC after induction culture and showed mainly soluble expression (Figure 3).
1
C
2
3
M kDa
9
6
7.2
6.4
4
4.3
KshC
Figure 3. SDS-PAGE analysis of proteins in the parent bacteria and recombinant bacteria. M: protein
marker (kDa); C: supernatant of E. coli BL21/pEtDuet-1; 1: sediment of E. coli BL21/pEtDuet-1-kshC
2
: supernatant of E. coli BL21/pEtDuet-1-kshC; 3: purified supernatant of E. coli BL21/pEtDuet-1-kshC.

Molecules 2019, 24, 2534
5 of 13
The size of both kshC and kshA is 1164 bp, and the sequence identity of these two genes is 67.25%.
The identity between kshC and kshB is only 34.91%; therefore, it was speculated that the KshC protein
functions as an oxygenase. To confirm this conjecture, the crude KshC enzyme solution was mixed
with a crude KshA or KshB enzyme solution and then added to the transformation system used for
the biotransformation of AD. The results showed that KshC and KshB catalyzed the conversion of
AD to 9-OH-AD; conversely, the mixture of KshC and KshA could not catalyze the reaction, proving
that KshC is indeed a KSH oxygenase component. More importantly, compared with KshA and KshB,
KshC and KshB had higher catalytic efficiency and 9-OH-AD productivity.
2
.2. Purification and Characterization of the KshB Protein
After the ultrasonic fragmentation of bacteria obtained from the induction culture, a crude enzyme
solution was obtained by collecting the supernatant after high-speed frozen centrifugation. KshB was
purified using a Ni affinity chromatography column. The purification of the target protein was validated
by SDS-PAGE and the results are shown in Figure 3b. There is a specific band near 45 kDa that corresponds
to the relative theoretical molecular weight calculated for the target protein (approximately 37.48 kDa),
and the activity of KshB was 11.73 U/mg. Consistent to previous findings, harboring a flavin and a
plant-type iron-sulfur cluster [28], the purified KshB presented an orange color, and NADH was a strict
electron donor when the reductase activity of KshB was assayed with DCPIP [6]. The optimal temperature
◦
◦
for KshB was 30 C, and the enzyme was relatively stable under 30 C (Figure 4a). The optimal pH
for KshB was 7.0 (Figure 4b). The figure indicates that the purified KshB protein showed more stable
activity in a wide pH range; thus, the purified enzyme was less sensitive to the pH than to temperature.
2+
3+
2+
2+
2+
+
+
Regarding metal ions, KshB was inhibited by Ba , Al , Ni , Zn , and Co ; conversely, K , Na ,
Ca , and EDTA had obvious activation effects on KshB (Figure 4c).
2+
Temperature optimal
Thermal stability
pH optimal
pH stability
a
1
20
00
120
100
80
60
40
20
0
b
1
8
6
4
2
0
0
0
0
0
0
20
40
60
80
2
4
6
8
10
Temperature C
pH
c
140
120
100
80
60
40
20
0
+
+
2+
2+
2+
3+
2+
2+
2+
CK
K
Na Ca Mg Ba Al Ni Zn Co EDTA
Figure 4. Enzymatic characterizations of KshB. (a) Temperature optimum and thermal stability of KshB.
(
b) pH optimum and pH stability of KshB. (c) Effect of metal ions and EDTA on KshB activity.

Molecules 2019, 24, 2534
6 of 13
2
.3. Optimization of the Terminal Oxygenase and Ferredoxin Reductase Ratio in an Enzyme-Liquid
Transformation System
According to the analysis of the temperature stability of the enzymatic properties of KshB,
◦
◦
the enzyme is relatively stable at 30 C or lower; therefore, the temperature was controlled at 30 C.
The role of an oxygenase requires an adequate amount of oxygen by increasing the agitation speed of
the catalytic process to increase the oxygen content. Under such an optimized condition, the conversion
of AD to 9-OH-AD by KSH can be more effective. The optimal ratio (crude enzyme) of KshB to KshC
content was 1.5:1 while that of KshB to KshA was 1:1 (Figure 5) because the activity of an oxygenase is
more stable in a reducing environment or the oxygenase would be easily inactivated. Thus, more KshB
is needed to provide a reducing environment for KshC. However, the activity of KshA is, to some
degree, lower than that of KshC; therefore, more KshA is required. The optimal ratio of KshB to KshC
of 1.5:1 was employed in the following experiments. Under optimal conditions, KshC with KshB can
produce approximately 5.9 g/L of 9-OH-AD in 6 h with a 97.5% conversion rate (mol/mol) in contrast
to 1.8 g/L by KshA with KshB.
KshB/KshA
KshB/KshC
7
6
5
4
3
2
1
0
0.5:1
1:1
1.5:1
2:1
2.5:1
Ratio of KshB/KshA and KshB/KshC
Figure 5. Optimization of the oxygenase and reductase ratio of KSH (KshB/KshA and KshB/KshC).
The reaction was performed in 50 mM Tris-HCl buffer (pH 7.0) containing 105 mM NADH and 20 mM
◦
AD, and was assayed at 30 C. All assays were performed in triplicate, and standard deviations of the
biological replicates are shown.
2
.4. Coupled Reaction of Hydroxylation and NADH Regeneration and the Optimization of the
Transformation System
The regeneration of NADH contributes to a more economical reaction because the conversion
process from AD to 9-OD-AD needs NADH as the electron acceptor. Thus, KSH from Mycobacterium sp.
VKM Ac-1817D and FDH from Candida boidinii were coupled in this work by separately overexpressing
them in E. coli BL21 (DE3). The crude enzyme activities of the recombinants used in the NADH
regeneration system are listed in Table 1.

Molecules 2019, 24, 2534
7 of 13
Table 1. Assays of KshB, KSH, and FDH activity in various strains.
Activity
U/mL)
Total Protein
(mg/mL)
Specific Activity
(U/mg protein)
Strains
Enzymes Substrate
(
E. coli BL21 (DE3)
E. coli BL21 (DE3)
E. coli BL21 (DE3)
KshB
FDH
KSH
KshB
FDH
KSH
DCPIP
NADH
AD
DCPIP
NADH
AD
0.64 ± 0.03
11.71 ± 0.15
12.21 ± 0.18
2.095 ± 0.07
11.25 ± 0.23
12.13 ± 0.12
2.07 ± 0.08
0.05 ± 0.002
n.d.
n.d.
n.d.
n.d.
BL21 (DE3)/pET-28a(+)-kshB
BL21 (DE3)/pET-28a(+)-fdh
BL21(DE3)/pEtDuet-1-kshC
33.32 ± 0.12
0.48 ± 0.02
0.91 ± 0.06
2.96 ± 0.12
0.04 ± 0.002
0.43 ± 0.02
n.d., not detected enzyme activity; All assays were performed in triplicate, and standard deviations of the biological
replicates are shown.
In the mixed multi-enzyme catalyst, the conditions required by each enzyme should be taken into
◦
account, such as temperature and pH conditions. The optimal temperature for KshB activity is 30 C,
and the pH optimal of KshB is 7.0. As reported in a previous work, the optimal pH and temperature
◦
conditions of FDH used in this work were approximately from pH 6.5 to 8.5 and 37 C, respectively [29].
To make the enzymes play more comparative roles in the coupled reaction, the biocatalytic conditions
should be optimized. As shown in Figure 6, the optimal pH, temperature, solvents, and ratio of KSH to
◦
FDH of the reaction were investigated. The results showed that pH 7.5 (Figure 6a) and 30 C (Figure 6b)
were optimal and were thus selected and employed in the following experiments.
a
0.8
0.5
b
0.4
0.3
0.2
0.1
0.0
0.6
0.4
0.2
0.0
5
6
7
8
9
10
11
20
25
30
35
40
45
pH
Temperature C
c
0.8
5
4
3
2
1
0
d
0.6
0.4
0.2
0.0
1:0
1:0.5
1:1
1:1.5
1:2
in
o
l
o
l
t
e
0
8
CK
g
r
h
n
a
e
a
t
n
e
c
o
h
e
ly
l al
c
t
c
a
e
e
w
T
l
Ratio of KSH to FDH
y
m
y
p
th
o
e
r
p
o
is
Figure 6. Optimization of the transformation system. (
a
) Effect of reaction pH on 9-OH-AD productivity
represented as 9-OH-AD concentration per liter transfer solution per hour) by the enzymatic system.
) Effect of reaction temperature on 9-OH-AD productivity by the enzymatic system. ( ) Effect of
) Effect of KSH to FDH ration on
-OH-AD productivity by the enzymatic system. When optimizing the effect of pH, temperature,
(
(
b
c
co-solvents on 9-OH-AD productivity by the enzymatic system. (
9
d
and co-solvents on the enzymatic system, FDH was supplied excessively. All assays were performed in
triplicate, and standard deviations of the biological replicates are shown.

Molecules 2019, 24, 2534
8 of 13
Considering that the substrate is insoluble in water, we tested the auxiliary effects of many solvents,
including glycerin, isopropyl alcohol, methanol, ethyl acetate, and Tween 80. The concentrations
of co-solvents were selected at 2% (v/v), as reported in our previous work [30]. Ethyl acetate was
considered to be the best co-solvent (Figure 6c). It was inferred that AD dissolved in ethyl acetate may
be more homogeneous in a water phase transformation system. Another probable reason is that ethyl
acetate leads to only minor damage in enzyme activity.
The KSH to FDH ratio was further investigated while the ratio of KshB to KshC was maintained
at 1.5:1 (Figure 6d). It can be concluded that 1:0.5 is the favorable ratio of KSH to FDH activity in a
6
-h catalysis, and 3.88 g/L of 9-OH-AD was produced, which is 4.17-fold higher than that produced
when no FDH was added (0.93 g/L). However, further increases in the proportion of FDH activity
failed to improve the yield of 9-OH-AD. Therefore, we used the ratio of 1:0.5 (KSH to FDH activity) in
subsequent experiments.
2
.5. Fed-Batch Conversion under Optimal Conditions for the Biocatalysis of 9-OH-AD
Conversion strategies can be applied to improve the concentration of desired product. Considering
the low solubility of AD and its inhibition effect to enzymes, we employed fed-batch strategy by
feeding 1.0 g/L of AD into the conversion system per hour. As shown in Figure 7, 7.14 g/L of 9-OH-AD
was transformed from AD over the first seven batches. However, the total 9-OH-AD production
grew slowly after the eighth batch, because high concentration of 9-OH-AD inhibits KSH activity
(Supplementary File 2: Figure S2). Finally, after 11 h of bioconversion, a total of 8 g/L of AD was
transformed into 7.78 g/L of 9-OH-AD with a conversion rate of 92.11% (mol/mol).
9
120
9
-OH-AD production
FDH
KSH
8
7
6
5
4
3
2
1
0
1
8
6
4
2
0
00
0
0
0
0
0
2
4
6
8
10
12
Time h
Figure 7. Time courses of fed-batch bioconversion from AD to 9-OD-AD by KSH and FDH.
The production of 9-OD-AD and enzyme activities of KSH and FDH were assayed. All assays
were performed in triplicate, and standard deviations of the biological replicates are shown.

Molecules 2019, 24, 2534
9 of 13
3
. Materials and Methods
3
.1. Chemicals, Primers, Plasmids, and Bacterial Strains
The standard samples of AD and 9-OH-AD were purchased from Sigma-Aldrich Co. LLC (Shanghai,
China). The yeast extract and the tryptone were purchased from Oxoid Ltd. (Basingstoke Hampshire,
England). All other chemicals were obtained from Sangon Biotech., Ltd. (Shanghai, China) and were of
analytical grade. The primers, plasmids, and bacterial strains used in this study are listed in Table 2.
3
.2. Construction of Recombinant Plasmids and Strains
The Mycobacterium sp. strain VKM Ac-1817D ksh genes kshA, kshB, and kshC encoding KshA, KshB,
and KshC were codon-optimized and synthesized by Sangon Biotech., Ltd. (Codon optimized sequences
were listed in Supplementary File 5). Using primer pairs P1/P2 and P3/P4, kshA and kshB were amplified
by PCR for further expression KshA and KshB on plasmid pET-28a(+), respectively. P5/P6 and P7/P6
were used to amplify the kshC gene by PCR for further expression of KshC on plasmids pET-28a(+)
and pEtDuet-1, respectively. The over-expressed enzymes were fused with His-Tags upstream of their
amino acids sequences. The PCR protocol has been described previously by Zhang et al. [31]. Plasmids
pET-28a(+)-kshA, pET-28a(+)-kshB, pET-28a(+)-kshC and pEtDuet-1-kshC were constructed by ligation of
the gene fragments and the linearized plasmids after digestion using the relevant restriction enzymes.
The plasmids were then transformed into E. coli BL21 (DE3) cells using the calcium chloride method.
Modified FDH was obtained from our laboratory [29]. Luria-Bertani (LB) medium containing peptone
(10 g/L), yeast extract (5 g/L), and NaCl (10 g/L) was used for strain cultivation, and kanamycin (Km,
100 mg/mL) or ampicillin (Amp, 200 mg/mL) was added when needed.
Table 2. Bacterial strains, plasmids, and primers used.
Strains/Plasmids/Primers
Characteristics
Source
Strains
Escherichia coli
E. coli BL21(DE3)
F- dcm ompT hsdS (rB- mB-) gal λ(DE3)
BL21 (DE3) containing pET-28a(+) (Km )
BL21 (DE3) containing pET-28a(+)-kshA (Km )
BL21 (DE3) containing pET-28a(+)-kshB (Km )
Invitrogen
This study
This study
This study
This study
This study
This study
This study
R
BL21 (DE3)/pET-28a(+)
BL21 (DE3)/pET-28a(+)-kshA
BL21 (DE3)/pET-28a(+)-kshB
BL21 (DE3)/pET-28a(+)-kshC
BL21 (DE3)/pET-28a(+)-fdh
BL21 (DE3)/pEtDuet-1
BL21 (DE3)/pEtDuet-1-kshC
Plasmids
R
R
R
BL21 (DE3) containing pET-28a(+)-kshC (Km )
R
BL21 (DE3) containing pET-28a(+)-fdh (Km )
R
BL21 (DE3) containing pEtDuet-1 (Amp )
R
BL21 (DE3) containing pEtDuet-1-kshC (Amp )
R
pET-28a(+)
pET-28a(+)-kshA
pET-28a(+)-kshB
pET-28a(+)-kshC
pET-28a(+)-fdh
pEtDuet-1
Expression plasmid, Km , T7 promoter
This lab
This study
This study
This study
This lab
pET-28a(+) containing kshA
pET-28a(+) containing ksbB-His
pET-28a(+) containing kshC
pET-28a(+) containing fdh
R
Expression plasmid, Amp , T7 promoter
This lab
pEtDuet-1-kshC
Primers (5 -3 )
pEtDuet-1 containing kshC-His
This study
0
0
P1
P2
P3
P4
P5
CGGGATCCATGACGACTGAGCACGCCGG
CCCAAGCTTTCAGCTTGATTGAGCGGTTTC
CGGGATCCATGACTGATGAACCGTTAGGTAG
CCCAAGCTTTCACTCGTCGTAGGTCACCTC
CGGGATCCGATGGCCGGTCTGAACAACGATAG
CCCAAGCTTTCAGCCGCTGGCCGGGGCGGCC
CGGGATCCGATGGCCGGTCTGAACAACGATAG
P6
P7
R
R
Amp , ampicillin-resistant; Km , kanamycin-resistant, The restriction enzyme sites are underlined.

Molecules 2019, 24, 2534
10 of 13
3
.3. Expression and Purification of Enzymes
A single colony of recombinant strains was inoculated into LB medium containing corresponding
◦
antibiotics and incubated on a rotary shaker (180 rpm, 37 C) to an optical density at 600 nm of about 0.8.
Isopropyl
β
-D-1-thiogalactopyranoside (IPTG, 80 mg/mL) was added to LB medium for inducing the
◦
expression of proteins, and the culture was then grown at 25 C for 12 h on a rotary shaker at 180 rpm.
The induced cells were centrifuged, washed three times by 50 mM PB buffer (Na HPO -NaH PO ,
2
4
2
4
pH 7.5), and then re-suspended in PB buffer. The cells were sonicated and centrifuged to obtain a
crude enzyme solution. The crude enzyme solution was purified using a Ni-ATA sepharose prepacked
column HisTrap HP (GE Healthcare, Uppsala, Sweden). The pooled fractions were then loaded on a
SuperdexTM 200 (10/300GL), equilibrated with 20mM Tris-HCl (pH 8.0) and 150 mM NaCl, using an
ÄKTA Protein Purifier system (Pharmacia, Uppsala, Sweden). According to the different chelation
degree of His-Tag and nickel ion, the protein was linearly eluted by an elution buffer with different
concentrations of imidazole, and the purified enzyme solutions were checked by SDS-PAGE.
3
.4. Assay of KshB, KSH, and FDH Activities
The KSH and FDH crude enzymes were prepared following the protocols described by Qi et al. [32]
.
For assaying the enzyme activity of KshB, the system included the following: 0.1 mM DCPIP, 50 mM
Tris-HCl buffer (pH 7.0), and 0.25 mM NADH; the role of coenzyme NADH is to provide electrons
as an electron donor via the reductase activity of KshB, and DCPIP serves as the electron acceptor.
The reaction is chromogenic, and DCPIP is soluble in the Tris-HCl buffer solution after turning dark
blue. Once the original state is restored, the color of DCPIP fades and becomes colorless. Upon
adding a certain amount of pure KshB enzyme or thick enzyme sample fluid, the change in the OD340
absorbance value was determined.
The system used to measure KSH enzyme activity included 105 mM NADH, 200 mM AD substrate
(
soluble in 100% isopropyl alcohol), 50 mM Tris-HCl buffer (pH 7.0), and KSH enzyme (including an
oxygenation component and a reduction component). After incorporating NADH, Tris-HCL buffer,
and KSH enzyme, a certain amount of AD substrate in isopropyl alcohol was added and the change in
the OD340 absorbance value was determined; a unit of enzyme activity was defined as the amount of
+
enzyme required to catalyze the conversion of 1
µ
mol of NADH to NAD within 1 min [
6]. FDH activity
was assayed as described by Berrios-Rivera et al. [33]. The protein concentrations were determined
using the Bradford Protein Assay Kit.
3
.5. Characterization of KshB
For the temperature optimum assay of KshB, the reactions were conducted at different temperatures
◦
◦
ranging from 0 to 80 C with a gradient of 10 C. For the KshB thermal stability assay, the enzyme
◦
was pre-incubated at different temperatures for 5 h and then assayed at 30 C. The following buffers
were used to investigate the pH dependence of KshB: 0.1M HAc-NaAc (pH 2–4), Na HPO -NaH PO
4
2
4
2
(pH 5–7), and Tris-HCl (pH 8–10). The pH stability of KshB was investigated using the standard
KshB assay after it had been pre-incubated at different pH buffers for 5 h. Metal ions and EDTA were
investigated to verify their effects on KshB activity. After the KshB is dialyzed with 0.1 M Tris-HCl
buffer, 0.1 mM metal ions and EDTA were added separately into the enzyme samples, which were then
assayed under the standard condition.
3
.6. Optimization of Conversion Conditions
The ratios of KSH reductase and oxygenase were optimized to achieve high conversion efficiency.
The assays were performed in 50 mM Tris-HCl buffer (pH 7.0) containing 105 mM NADH and 20 mM
◦
AD at 30 C, and the enzyme activities of the two components (KshB/KshA and KshB/KshC) were
arranged as 0.5:1, 1:1, 1.5:1, 2:1, and 2.5:1, respectively.

Molecules 2019, 24, 2534
11 of 13
When coupling KSH and FDH to construct a NADH regeneration system, 1 M ammonium
formate was added as the co-substrate and the initial NADH concentration was 0.32 mM. The pH and
temperature optimal of the NADH regeneration system were also optimized. The pH optimal was
assayed under different pH conditions ranging from pH 5.5 to 10.5, and the temperature dependence
◦
◦
was assayed at different temperatures ranging from 20 to 45 C with a gradient of 5 C. The effects of
co-solvents on 9-OH-AD productivity by the enzymatic system were also investigated. Glycerin 2%
(
v/v), isopropyl alcohol, methanol, ethyl acetate, and Tween 80 were added separately as co-solvents
into the reaction solution. The ratio of KSH/FDH was optimized with their comparative activities at
:0, 1:0.5, 1:1, 1:1.5, and 1:2, respectively.
1
3
.7. Production of 9-OH-AD by Fed-Batch Conversion
When applying the fed-batch conversion strategy, KSH and FDH were added according to the
optimal ratio of the enzyme activities. The enzymatic reaction was conducted in Tris-HCl buffer (50 mM)
◦
and was maintained at pH 7.5 on a magnetic stirrer at 30 C and 160 rpm. The initial concentration of
ammonium formate and NADH was 1 M and 0.32 mM, respectively. AD at a concentration of 1.0 g/L
was fed into the reaction solution per hour.
3
.8. Analysis of Products
One milliliter of reaction sample was extracted with 4 mL of ethyl acetate and centrifuged to obtain
supernatant for future determination. The concentrations of AD and 9-OH-AD were assayed via HPLC
with a UV detector at 254 nm using a C18 column (Diamonsil C18, 5-
µ
m particles, 250 mm × 4.6 mm).
The composition of methanol and water in the mobile phase was 7/3 (v/v). The column temperature was
0 C and the flow rate was set as 1 mL/min [34]. The conversion rate was calculated using the following
◦
3
equation: Conversion rate = m9-OH-AD/mAD, where m9-OH-AD is the titer of 9-OH-AD produced from AD
and mAD is the titer of the substrate AD. The results of the HPLC samples are shown in Supplementary
File 3: Figure S3.
After conversion of AD in the reaction solution, a mass of transformation products was extracted
with ethyl acetate and then re-dissolved in methanol. The transformation products were separated by
silica gel column chromatography; the eluent was petroleum ether/ethyl acetate system, the volume
ratio of petroleum ether and ethyl acetate is 6:4, and the flow rate was 1–2 mL/min. The eluent
was concentrated and vacuum treated and then analyzed by TLC to obtain the purified product.
The structures of the purified product were elucidated by Avance III 400 MHz nuclear magnetic
resonance (NMR) (1HNMR USES CD4O as a solvent). The NMR result of 9-OH AD is shown in
Supplementary File 4: Figure S4.
4
. Conclusions
In this work, the ksh genes from Mycobacterium sp. strain VKM Ac-1817D were cloned and
overexpressed in E. coli BL21 (DE3). The function of a novel 3-phytosterone-9 -hydroxylase oxygenation
α
component (KshC) was identified to have higher catalytic efficiency than the known oxygenation
component (KshA). Then, an enzyme-mediated hydroxylation system for 9-OH-AD production was
designed and successfully developed by applying KSH (KshB and KshC) coupled with NADH
regeneration via FDH. Through optimization of the conversion conditions, type of solvent, ratio of
enzymes, and applying of a fed-batch strategy, the conversion rate of AD to 9-OH-AD was greatly
improved. This study provides a promising bioconversion method for 9-OH-AD production.
Supplementary Materials: Supplementary Materials are available online. Supplementary File 1: Figure S1.
Identification of the recombinant plasmids pET-28a-kshA, pET-28a-kshB and pET-28a-kshC. Supplementary File 2:
Figure S2. Effect of 9-OH-AD on the activity of KSH. Supplementary File 3: Figure S3. HPLC result of AD
and 9-OD-AD. (a) Standard sample of 9-OH-AD; (b) Standard sample of AD; (c) Conversion results at 0 h;
(
d) Conversion results at 6 h. Supplementary File 4: Figure S4. NMR result of 9-OH-AD. Supplementary File 5:
Sequences of codon optimized kshA, kshB, and kshC.

Molecules 2019, 24, 2534
12 of 13
Author Contributions: Conceptualization, J.X. and Z.R.; data curation, X.Z. and M.Z.; formal analysis, R.H., Y.Z.,
K.C., K.Q., M.S., T.Y., and M.X.; Writing—original draft, X.Z.
Funding: This work was supported by the National Natural Science Foundation of China (31500065, 21778024,
3
1870066), the National Key Research and Development Program of China (2018YFA0900304), national
first-class discipline program of Light Industry Technology and Engineering (LITE2018-06), key research and
development program of Ningxia hui autonomous region (2017BY069, 2019BCH01002), the science and technology
innovation team foundation of Ningxia hui autonomous region (KJT2017001), the Top-Notch Academic Programs
Project of Jiangsu Higher Education Institutions, 111 Project, Program of the Key Laboratory of Industrial
Biotechnology, Ministry of Education, China (KLIB-KF201902), the General Project of Beijing Municipal Education
Commission (SQKM201311417004), the Opening Foundation of Beijing Key Laboratory of Biomass Waste Resource
Utilization, Jiangsu province “Collaborative Innovation Center for Advanced Industrial Fermentation” industry
development program.
Conflicts of Interest: The authors declare that they have no conflicts of interest.
References
1
.
Donova, M.V.; Egorova, O.V. Microbial steroid transformations: Current state and prospects.
Appl. Microbiol. Biotechnol. 2012, 94, 1423–1447. [CrossRef] [PubMed]
2
.
Wovcha, M.G.; Antosz, F.J.; Knight, J.C.; Kominek, L.A.; Pyke, T.R. Bioconversion of sitosterol to useful
steroidal intermediates by mutants of Mycobacterium fortuitum. Biochim. Biophys. Acta 1978, 531, 308–321.
[CrossRef]
3
.
Fernandes, P.; Cruz, A.; Angelova, B.; Pinheiro, H.M.; Cabral, J.M.S. Microbial conversion of steroid
compounds: Recent developments. Enzym. Microb. Technol. 2003, 32, 688–705. [CrossRef]
Sedlaczek, L. Biotransformations of steroids. Crit. Rev. Biotechnol. 1988, 7, 187–236. [CrossRef] [PubMed]
Mutafov, S.; Angelova, B.; Avramova, T.; Boyadjieva, L.; Dimova, I. The inducibility of 9 alpha-steroid
hydroxylating activity in resting Rhodococcus sp. cells. Process Biochem. 1997, 32, 585–589. [CrossRef]
Petrusma, M.; Dijkhuizen, L.; van der Geize, R. Rhodococcus rhodochrous DSM 43269 3-Ketosteroid 9
alpha-Hydroxylase, a Two-Component Iron-Sulfur-Containing Monooxygenase with Subtle Steroid Substrate
Specificity. Appl. Environ. Microbiol. 2009, 75, 5300–5307. [CrossRef] [PubMed]
4
5
.
.
6
.
.
7
Brzostek, A.; Sliwinski, T.; Rumijowska-Galewicz, A.; Korycka-Machala, M.; Dziadek, J. Identification and
targeted disruption of the gene encoding the main 3-ketosteroid dehydrogenase in Mycobacterium smegmatis.
Microbiology 2005, 151, 2393–2402. [CrossRef]
8
9
1
.
Strijewski, A. The steroid-9 alpha-hydroxylation system from Nocardia species. Eur. J. Biochem. 1982, 128,
1
25–135. [CrossRef]
.
Dutta, R.K.; Roy, M.K.; Singh, H.D. Role of Plasmid Pjl1 Of Arthrobacter-Oxydans 317 In the Degradation of
Beta-Sitosterol. J. Basic Microbiol. 1992, 32, 317–324. [CrossRef]
0. van der Geize, R.; Hessels, G.I.; van Gerwen, R.; van der Meijden, R.; Dijkhuizen, L. Molecular and functional
characterization of kshA and kshB, encoding two components of 3-ketosteroid 9 alpha-hydroxylase, a class
IA monooxygenase, in Rhodococcus erythropolis strain SQ1. Mol. Microbiol. 2002, 45, 1007–1018. [CrossRef]
1. Tong, W.Y.; Dong, X. Microbial biotransformation: Recent developments on steroid drugs.
Recent Pat. Biotechnol. 2009, 3, 141–153. [CrossRef] [PubMed]
1
1
1
1
1
1
1
1
2. Peart, P.C.; McCook, K.P.; Russell, F.A.; Reynolds, W.F.; Reese, P.B. Hydroxylation of steroids by Fusarium
oxysporum, Exophiala jeanselmei and Ceratocystis paradoxa. Steroids 2011, 76, 1317–1330. [CrossRef] [PubMed]
3. Li, H.; Liu, H.M.; Ge, W.; Huang, L.; Shan, L. Synthesis of 7alpha-hydroxy-dehydroepiandrosterone and
7
beta-hydroxy-dehydroepiandrosterone. Steroids 2005, 70, 970–973. [CrossRef] [PubMed]
4. Lamm, A.S.; Chen, A.R.; Reynolds, W.F.; Reese, P.B. Steroid hydroxylation by Whetzelinia sclerotiorum,
Phanerochaete chrysosporium and Mucor plumbeus. Steroids 2007, 72, 713–722. [CrossRef] [PubMed]
5. Rupprecht, R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
Psychoneuroendocrinology 2003, 28, 139–168. [CrossRef]
6. Baker, M.E. Origin and diversification of steroids: Co-evolution of enzymes and nuclear receptors.
Mol. Cell. Endocrinol. 2011, 334, 14–20. [CrossRef] [PubMed]
7. Schule, C.; Eser, D.; Baghai, T.C.; Nothdurfter, C.; Kessler, J.S.; Rupprecht, R. Neuroactive steroids in affective
disorders: Target for novel antidepressant or anxiolytic drugs. Neuroscience 2011, 191, 55–77. [CrossRef]
8. Angelova, B.; Mutafov, S.; Avramova, T.; Dimova, I.; Boyadjieva, L. 9 alpha-hydroxylation of
4
-androstene-3,17-dione by resting Rhodococcus sp. cells. Process. Biochem. 1996, 31, 179–184. [CrossRef]

Molecules 2019, 24, 2534
13 of 13
1
2
9. Donova, M.V.; Gulevskaya, S.A.; Dovbnya, D.V.; Puntus, I.F. Mycobacterium sp. mutant strain producing
alpha-hydroxyandrostenedione from sitosterol. Appl. Microbiol. Biotechnol. 2005, 67, 671–678. [CrossRef]
0. Xian, Z.; Zhiming, R.; Zhang, L.; Meijuan, X.; Taowei, Y. Efficient 9 -hydroxy-4-androstene-3,17-dione
production by engineered Bacillus subtilis co-expressing Mycobacterium neoaurum 3-ketosteroid 9 -hydroxylase
and B. subtilis glucose 1-dehydrogenase with NADH regeneration. SpringerPlus 2016, 5, 1207.
1. Yao, K.; Xu, L.Q.; Wang, F.Q.; Wei, D.Z. Characterization and engineering of 3-ketosteroid- 1-dehydrogenase
and 3-ketosteroid-9alpha-hydroxylase in Mycobacterium neoaurum ATCC 25795 to produce
alpha-hydroxy-4-androstene-3,17-dione through the catabolism of sterols. Metab. Eng. 2014, 24, 181–191.
CrossRef] [PubMed]
9
α
α
2
2
∆
9
[
2. Bragin, E.Y.; Shtratnikova, V.Y.; Dovbnya, D.V.; Schelkunov, M.I.; Pekov, Y.A.; Malakho, S.G.; Egorova, O.V.;
Ivashina, T.V.; Sokolov, S.L.; Ashapkin, V.V.; et al. Comparative analysis of genes encoding key steroid core
oxidation enzymes in fast-growing Mycobacterium spp. strains. J. Steroid Biochem. Mol. Biol. 2013, 138, 41–53.
[
CrossRef] [PubMed]
3. Schroder, I.; Steckhan, E.; Liese, A. In situ NAD(+) regeneration using 2,2 ‘-azinobis(3-ethylbenzothiazoline-
-sulfonate) as an electron transfer mediator. J. Electroanal. Chem. 2003, 541, 109–115. [CrossRef]
4. van der Donk, W.A.; Zhao, H. Recent developments in pyridine nucleotide regeneration. Curr. Opin. Biotechnol.
003, 14, 421–426. [CrossRef]
2
2
2
2
6
2
5. Mesentsev, A.V.; Lamzin, V.S.; Tishkov, V.I.; Ustinnikova, T.B.; Popov, V.O. Effect of pH on kinetic parameters
+
of NAD -dependent formate dehydrogenase. Biochem. J. 1997, 321, 475–480. [CrossRef]
6. Matsuyama, A.; Yamamoto, H.; Kobayashi, Y. Practical application of recombinant whole-cell biocatalysts
for the manufacturing of pharmaceutical intermediates such as chiral alcohols. Org. Process. Res. Dev. 2002
, 558–561. [CrossRef]
,
6
2
7. Galkin, A.; Kulakova, L.; Yoshimura, T.; Soda, K.; Esaki, N. Synthesis of optically active amino acids from
alpha-keto acids with Escherichia coli cells expressing heterologous genes. Appl. Env. Microbiol. 1997, 63,
4
651–4656.
2
8. Batie, C.J.; LaHaie, E.; Ballou, D.P. Purification and characterization of phthalate oxygenase and phthalate
oxygenase reductase from Pseudomonas cepacia. J. Biol. Chem. 1987, 262, 1510–1518.
2
9. Zheng, J.X.; Yang, T.W.; Zhou, J.P.; Xu, M.J.; Zhang, X.; Rao, Z.M. Elimination of a Free Cysteine by
Creation of a Disulfide Bond Increases the Activity and Stability of Candida boidinii Formate Dehydrogenase.
Appl. Environ. Microbiol. 2017, 83, 2. [CrossRef]
3
0. Shao, M.; Zhang, X.; Zhiming, R.; Meijuan, X.; Yang, T.; Li, H.; Zhenghong, X.; Shangtian, Y.
Efficient testosterone production by engineered Pichia pastoris co-expressing human 17β-hydroxysteroid
dehydrogenase type 3 and Saccharomyces cerevisiae glucose 6-phosphate dehydrogenase with NADPH
regeneration. Green Chem. 2016, 18, 1774–1784. [CrossRef]
3
3
3
3
1. Zhang, X.; Xu, Z.; Liu, S.; Qian, K.; Xu, M.; Yang, T.; Xu, J.; Rao, Z. Improving the Production of Salt-Tolerant
Glutaminase by Integrating Multiple Copies of Mglu into the Protease and 16S rDNA Genes of Bacillus subtilis
1
68. Molecules 2019, 24, 592. [CrossRef] [PubMed]
2. Qi, Y.L.; Yang, T.W.; Zhou, J.P.; Zheng, J.X.; Xu, M.J.; Zhang, X.; Rao, Z.M.; Yang, S.T. Development of a
multi-enzymatic desymmetrization and its application for the biosynthesis of L-norvaline from DL-norvaline.
Process. Biochem. 2017, 55, 104–109. [CrossRef]
3. Berrios-Rivera, S.J.; Sanchez, A.M.; Bennett, G.N.; San, K.Y. Effect of different levels of NADH
availability on metabolite distribution in Escherichia coli fermentation in minimal and complex media.
Appl. Microbiol. Biotechnol. 2004, 65, 426–432. [CrossRef] [PubMed]
4. Shao, M.L.; Zhang, X.; Rao, Z.M.; Xu, M.J.; Yang, T.W.; Li, H.; Xu, Z.H. Enhanced Production of
Androst-1,4-Diene-3,17-Dione by Mycobacterium neoaurum JC-12 Using Three-Stage Fermentation Strategy.
PLoS ONE 2015, 10, 9. [CrossRef] [PubMed]
Sample Availability: Samples of the compounds are not available from the authors.
©
2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).